Long-term outcome of Ph-negative acute lymphoblastic leukaemia in adults: A single centre experience

Acta Haematologica

Volumn 113, Issue 4, 2005, Pages 234-240

  Castagnola, Carlo ^a,b   Lunghi, Monia ^a   Caberlon, Sabrina ^a   Bonfichi, Maurizio ^a   Pascutto, Cristiana ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Acute lymphoblastic leukaemia; Chemotherapy, efficacy in adults

Indexed keywords

ANTITHROMBIN III; ASPARAGINASE; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B LYMPHOCYTE; BLOOD CLOTTING DISORDER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CELL LINEAGE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OVARY CANCER; PATIENT REFERRAL; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; STANDARD; SURVIVAL TIME; T LYMPHOCYTE; THERAPY RESISTANCE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 21344462329     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084676     Document Type: Article

References (24)

1. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM: Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 1993;329:1289-1295.
2. Preti A, Kantarjian HM: Management of adult acute lymphocytic leukemia: Present issues and key challenges. J Clin Oncol 1994;12:1312-1322.
3. Laport GF, Larson RA: Treatment of adult acute lymphoblastic leukemia. Semin Oncol 1997;24:70-82.
4. Bassan R, Pogliani E, Casula P, Rossi G, Fabris P, Morandi S, Lambertenghi-Deliliers G, Vespignani M, Lerede T, Rambaldi A, Borleri G, Spedini P, Cortelezzi A, Izzi T, Coser P, Broccia G, Corneo G, Barbui T: Risk-oriented post-remission strategies in adult acute lymphoblastic leukemia: Prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups. Hematol J 2001;2:117-126.
5. Goekbuget N, Arnold R, Buechner T: Intensification of induction and consolidation improves only subgroups of adult ALL: Analysis of 1200 patients in the GMALL Study 05/93. Blood 2001;98:802a.
6. Mortuza FY, Papaioannou M, Moreira IM, Coyle LA, Gameiro P, Gandini D, et al: Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. J Clin Oncol 2002;20:1094-1104.
7. Rowe JM, Richards SM, Burnett AK, Wiernik PH, Harrison G, Lazarus HM, Franklin IM, Prentice GH, Durrant JI, Tallman MS, Goldstone AH. Favourable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2001;98:2009a.
8. Wetzler M, Dodge RK, Mrozek K, Carroll AJ, Tantravahi R, Block AW, Pettenati MJ, Le Beau MM, Frankel SR, Stewart CC, Szatrowski TP, Schiffer CA, Larson RA, Bloomfield CD: Prospective karyotype analysis in adult acute lymphoblastic leukemia: The cancer and leukemia Group B experience. Blood 1999;93:3983-3993.
9. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB: Proposal for the immunological classification of leukemias. Leukemia 1995;9:1783-1786.
10. Hoelzer D, Thiel E, Ludwig WD, Loffler H, Buchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Volkers B: Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group. Leukemia 1993;7(suppl 2):S130-S134.
11. Annino L, Vegna ML, Camera A, Specchia G, Visani G, Fioritoni G, Ferrara F, Peta A, Ciolli S, Deplano W, Fabbiano F, Sica S, Di Raimondo F, Cascavilla N, Tabilio A, Leoni P, Invernizzi R, Baccarani M, Rotoli B, Amadori S, Mandelli F; GIMEMA Group: Treatment of adult acute lymphoblastic leukemia (ALL): Long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002;99:863-871.
12. Goekbuget N, Arnold R, Buechner T: Intensification of induction and consolidation improves only subgroups of adult ALL. Blood 2001;98:802a.
13. Stock W, Dodge RK, Vardiman JW, Bloomfield CD, Caligiuri MA, Frankel SR, Stone RM, Larson RA, et al: Treatment of Adult Acute Lymphoblastic Leukemia (ALL): Phase II trial of dose intensification of daunorubicin and cytarabine followed by high-dose methotrexate and intrathecal methotrexate in place of cranial irradiation (CALGB 19802). Blood 2001;98:2472a.
14. Thiebaut A, Vernant JP, Degos L, Huguet FR, Reiffers J, Sebban C, Lepage E, Thomas X, Fiere D: Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am 2000;14:1353-1366.
15. Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA: A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111, Blood 1998;92:1556-1564.
16. Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ: Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000;18:547-561.
17. Durrant IJ, Prentice HG, Richards SM: Intensification of treatment for adults with acute lymphoblastic leukaemia: Results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults. Br J Haematol 1997;99:84-92.
18. Hallbook H, Simonsson B, Ahlgren T, Bjorkholm M, Carneskog J, Grimfors G, Hast R, Karlsson K, Kimby E, Lerner R, Linder O, Linderholm M, Lofvenberg E, Malm C, Nilsson PG, Paul C, Stenke L, Stockelberg D, Tidefelt U, Turesson I, Uden-Blome AM, Vilen L, Wahlin A, Winquist I. Smedmyr B: High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukemia. Br J Haematol 2002;118:748.
19. Linker C, Damon L, Ries C, Navarro W: Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol 2002;20:2464-2471.
20. Ribera JM, Ortega JJ, Oriol A, Fontanillas M, Hernandez-Rivas JM, Brunet S, Garcia-Conde J, Maldonado J, Zuazu J, Gardella S, Besalduch J, Leon P, Macia J, Domingo-Albos A, Feliu E, San Miguel JF: Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology. Haematologica 1998;83:222-230.
21. Bruggemann M, Droese J, Raff T, Ritgen M, Scheuring U, Goekbuget N, Hoelzer DF, Kneba M: The prognostic significance of minimal residual disease in adult standard risk patients with acute lymphoblastic leukemia. Blood 2001;98:314a.
22. Hoelzer D, Gökbuget N, Brüggemann M, Droese J, Scheuring U, Reutzel R, Thiel E, Kneba M, for the GMALL Study Group: Clinical impact of minimal residual disease (MRD) in trial design for adult ALL. Blood 2001;98:584a.
23. Sher D, Dodge RK, Bloomfield CD, Larson RA, Caligiuri MA, Stock W: Clone-specific quantitative real-time PCR of IgH or TCR gene rearrangements in adult acute lymphoblastic leukemia (ALL) following induction chemotherapy identifies patients with a poor prognosis: Pilot study from the Cancer and Leukemia Group B (CALGB 20101). Blood 2002;100:153a.
24. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002;1:133-143.